| Literature DB >> 28593824 |
Marzia Del Re1, Eleonora Rofi1, Valentina Citi2, Leonardo Fidilio1, Romano Danesi1.
Abstract
Letter in regards to: Del Re M, Rofi E, Citi V, Fidilio L, Danesi R. Should CYP2D6 be genotyped when treating with tamoxifen? Pharmacogenomics 17(18), 1967-1969 (2016). In response to: Damkier P. Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients. Pharmacogenomics 18(8), XXX (2017).Entities:
Keywords: CYP2D6; drug–drug interaction; pharmacogenetics; tamoxifen
Mesh：
Substances：
Year: 2017 PMID： 28593824 DOI： 10.2217/pgs-2017-0065
Source DB: PubMed Journal: Pharmacogenomics ISSN： 1462-2416 Impact factor: 2.533